Prospective Collection of Clinical Data and Human Body Material (HBM) of Cutaneous Melanoma, Non Melanoma Patients and Healthy Controls. Biobank Huidkanker
About this study
The goal of this clinical trial is to set up a prospective, fit-for-purpose collection of human body material (HBM)-blood (serum, plasma, DNA) and tissue-and standardized clinical data of patients with cutaneous melanoma, non-melanoma skin cancer and healthy controls. The main questions it aims to answer are: * To create a biobank with samples of human body material (HBM): blood (serum/plasma/DNA) and tissue and clinical data of patients with cutaneous melanoma, non-melanoma and helathy controls. * To support future research questions (after specific approval of the Ethics Committee) by using the biobank (through satellite protocols). If there is a comparison group: Not applicable (umbrella protocol for collection only). Participants will: * Share demographics, medical and surgical history, risk factors. * Complete Cancer Worry Scale questionnaire. * Provide biological samples: * Blood samples (serum, plasma, DNA). * Tissue samples (residual tissue or additional biopsy if consented).
- Condition
- Skin Cancer, Non-Melanoma, Skin Cancer Melanoma
- Tested
- Collection of Human Body Material and Clinical Data
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 6
- Minimum age: 18 years
- Study condition: Skin Cancer, Non-Melanoma, Skin Cancer Melanoma
- Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
- Adult subjects (\>18 years of age) at time of enrolment.
- Subjects diagnosed with cutaneous melanoma, Non-melanoma skin cancer or healthy controls.
- Adult subjects able and willing to provide informed consent.
Exclusion 2
- Subjects unable or not willing to provide informed consent.
- Pregnancy (or willing to become pregnant) is NOT an exclusion criteria (unless specified in the respective satellite protocols.
Where
1 site, 1 recruiting
UZLeuven, Department of Dermatology
Leuven, Vlaams-Brabant, Belgium
Contact
-
Annemiek Leeman, Prof. Dr.
0032 016337950 annemiek.leeman@uzleuven.be
-
Sofie Van Kelst, BSc
0032 016337864 sofie.vankelst@kuleuven.be
Potential match only. Final eligibility is determined by the study team.